Nosocomial infections caused by Acinetobacter baumannii often prove difficult to treat owing
to their multiple drug resistance. Carbapenems play a pivotal role in the management of …

The wide use of carbapenems for empirical therapy of nosocomial infections caused by
Acinetobacter baumannii has resulted in emergence of an additional type of resistance; the …

Background: One leading factor responsible for resistance in Acinetobacter baumannii, an
important opportunist in health care institutions globally, is the production of …

Acinetobacter baumannii (A. baumannii) has been known as a causative pathogen of
hospital acquired infections. The aim of this study is to examine the presence of A …

Introduction: Acinetobacter baumannii is an emerging multi-drug resistant opportunistic
pathogen that causes a variety of nosocomial infections. In recent years, carbapenem …

Acinetobacter baumannii is an important cause of hospital-acquired infections. The
occurrence of carbapenem resistance that is caused by the carbapenem-hydrolysing class …

ABSTRACT A total of 87 Acinetobacter baumannii nonrepetitive consecutive clinical isolates
were tested for the presence of metallo-β-lactamases (MBLs). Results of phenotypic assays …

Metallo-b-lactamase (MBL)-producing Acinetobacter baumannii has become a growing
therapeutic concern worldwide. The aims of this study were to evaluate the antimicrobial …

Multidrug resistant A. baumannii has emerged as an important and problematic human
pathogen as it is the causative agent of several types of infections especially in neonates …

Background Acinetobacter baumannii is an opportunistic microorganism with an increasing
role in nosocomial outbreaks. For the last 2 decades, a growing number of carbapenem …